|Articles|May 7, 2004
Sales growth boosts Alcon earnings 46.7%
Almost everything clicked for Alcon Inc. during the first quarter of 2004, as the company recorded global sales of $963.6 million, an increase of 19.4% from the first quarter of 2003.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
2
FDA approves Amneal Pharmaceuticals' cyclosporine ophthalmic emulsion 0.05%
3
Avisi Technologies treats first patient in SAPPHIRE trial for glaucoma
4
Inflammasome Therapeutics completes phase 2 trial enrollment for K8 in GA
5











































.png)


